🔎 Trials Near Me

ホーム › 高血圧 › オハイオ

オハイオにおける高血圧の臨床試験

オハイオ内の拠点で、高血圧に関する18件の研究が参加者を募集しています。

オハイオ内の都市

公式研究テキスト(英語)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • Retension Clinical Site, Cincinnati
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07142356

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • The Christ Hospital, Cincinnati
  • Velocity Clinical Research-Cincinnati-69044, Cincinnati
  • Centricity Research-Columbus-68879, Columbus
  • 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

  • Research Innovations, LLC, Beavercreek
  • Cleveland Clinic, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07511361

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Remington-Davis, Inc, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Canton
  • Research Site, Cincinnati
  • Research Site, Cincinnati
  • 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Beavercreek
  • Clinical Trial Site, Cincinnati
  • Clinical Trial Site, Cincinnati
  • 他7件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Cincinnati Childrens Hospital Medical Center, Cincinnati
被験者募集中観察研究健康なボランティア歓迎
0歳〜20歳 · 全性別 · 2026/08/21更新 · NCT04278404

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

  • Cleveland Clinic Akron General, Akron
  • Cleveland Clinic Foundation, Cleveland
  • ProMedica Toledo Hospital, Toledo
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2026/08/07更新 · NCT06402968

Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study

  • Cleveland Clinic, Cleveland
被験者募集中
18歳以上 · 女性 · 2026/08/03更新 · NCT07363343

Office, Home, and Ambulatory Blood Pressure

  • Cincinnati Children's Hospital, Cincinnati
被験者募集中観察研究
6歳〜19歳 · 全性別 · 2026/06/25更新 · NCT05297708

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

  • Case Western Reserve University, Cleveland
被験者募集中
50歳以上 · 全性別 · 2026/04/03更新 · NCT05293756

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Cincinnati
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/02/27更新 · NCT07090161

Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic

  • Cleveland Clinic, Cleveland
被験者募集中観察研究
18歳〜85歳 · 全性別 · 2026/01/09更新 · NCT07232017

Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes

  • Cleveland Clinic Main Campus, Cleveland
  • Cleveland Clinic Hillcrest, Mayfield Heights
被験者募集中
18歳以上 · 全性別 · 2026/01/08更新 · NCT07208669

Home BP Monitoring

  • University Hospitals Cleveland Medical Center, Cleveland
被験者募集中健康なボランティア歓迎
13歳〜18歳 · 全性別 · 2025/12/10更新 · NCT05552547

Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention

  • The Ohio State University, Columbus
被験者募集中
18歳以上 · 男性 · 2025/10/06更新 · NCT06055036

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。